← Leaderboards
Bruce D Uhal
Michigan State University
$2,864,172
Attributed
$2,864,172
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $299.1K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,864,172 · 1
By mechanism
R01$2,864,172 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisLung InjuryFibroblastsRespiratory EpitheliumPulmonary Fibrosis /GranulomaAngiotensinogenAmiodaroneProtease InhibitorBleomycinAngiotensinsGene ExpressionAngiotensin ReceptorAlveolar Type Ii CellAngiotensin IiFibrosisIn VivoEventEnzymesEpithelialCell Growth RegulationAngiotensin-Converting Enzyme InhibitorsEpithelial CellsAnimal ModelCell Proliferation
Grant awards (13)
Control of Type II Pneumocyte Proliferation$295,066
R01 · FY2012 · HL · contact PI
Control of Type II Pneumocyte Proliferation$298,437
R01 · FY2011 · HL · contact PI
Control of Type II Pneumocyte Proliferation$298,801
R01 · FY2010 · HL · contact PI
Control of Type II Pneumocyte Proliferation$299,141
R01 · FY2009 · HL · contact PI
CONTROL OF TYPE II PNEUMOCYTE PROLIFERATION$212,629
R01 · FY2007 · HL · contact PI
CONTROL OF TYPE II PNEUMOCYTE PROLIFERATION$212,779
R01 · FY2006 · HL · contact PI
CONTROL OF TYPE II PNEUMOCYTE PROLIFERATION$243,396
R01 · FY2005 · HL
CONTROL OF TYPE II PNEUMOCYTE PROLIFERATION$2,673
R01 · FY2005 · HL
CONTROL OF TYPE II PNEUMOCYTE PROLIFERATION$224,250
R01 · FY2004 · HL
CONTROL OF TYPE II PNEUMOCYTE PROLIFERATION$185,000
R01 · FY2003 · HL
CONTROL OF TYPE II PNEUMOCYTE PROLIFERATION$185,000
R01 · FY2002 · HL
CONTROL OF TYPE II PNEUMOCYTE PROLIFERATION$222,000
R01 · FY2001 · HL
CONTROL OF TYPE II PNEUMOCYTE PROLIFERATION$185,000
R01 · FY2000 · HL